共 171 条
[1]
Hardisson D(2003)Molecular pathogenesis of head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 260 502-508
[2]
Ho PS(2002)The incidence of oropharyngeal cancer in Taiwan: an endemic betel quid chewing area J Oral Pathol Med 31 213-239
[3]
Ko YC(2007)Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study Am J Clin Oncol 30 278-282
[4]
Yang YH(1992)A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck J Clin Oncol 10 257-263
[5]
Shieh TY(1992)Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study J Clin Oncol 10 1245-1251
[6]
Tsai CC(1994)Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group Ann Oncol 5 521-526
[7]
Labourey JL(2008)Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer J Chin Med Assoc 71 336-341
[8]
Cupissol D(1998)Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group Trial (PA 390) Cancer 82 2270-2274
[9]
Calais G(1994)Docetaxel (Taxotere): an active drug of the treatment of patients with advanced squamous cell carcinoma of the head and neck Ann Oncol 5 533-537
[10]
Tourani JM(2005)Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group J Clin Oncol 23 3562-3567